American International Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,515
| Closed | -$429K | – | 2656 |
|
|
2024
Q1 | $429K | Buy |
24,515
+3,266
| +15% | +$57.2K | ﹤0.01% | 1738 |
|
|
2023
Q4 | $463K | Buy |
21,249
+189
| +0.9% | +$4.12K | ﹤0.01% | 1705 |
|
|
2023
Q3 | $323K | Buy |
21,060
+748
| +4% | +$11.5K | ﹤0.01% | 1850 |
|
|
2023
Q2 | $483K | Buy |
20,312
+1,861
| +10% | +$44.3K | ﹤0.01% | 1659 |
|
|
2023
Q1 | $469K | Buy |
18,451
+561
| +3% | +$14.3K | ﹤0.01% | 1637 |
|
|
2022
Q4 | $523K | Buy |
17,890
+5,296
| +42% | +$155K | ﹤0.01% | 1562 |
|
|
2022
Q3 | $258K | Buy |
12,594
+516
| +4% | +$10.6K | ﹤0.01% | 2012 |
|
|
2022
Q2 | $140K | Buy |
+12,078
| New | +$140K | ﹤0.01% | 2400 |
|
|
2019
Q2 | – | Sell |
-1,105
| Closed | -$46K | – | 3154 |
|
|
2019
Q1 | $46K | Sell |
1,105
-36
| -3% | -$1.5K | ﹤0.01% | 2901 |
|
|
2018
Q4 | $52K | Sell |
1,141
-9
| -0.8% | -$410 | ﹤0.01% | 2877 |
|
|
2018
Q3 | $96K | Buy |
1,150
+36
| +3% | +$3.01K | ﹤0.01% | 2864 |
|
|
2018
Q2 | $107K | Buy |
1,114
+388
| +53% | +$37.3K | ﹤0.01% | 2750 |
|
|
2018
Q1 | $76K | Buy |
726
+135
| +23% | +$14.1K | ﹤0.01% | 2782 |
|
|
2017
Q4 | $93K | Buy |
591
+26
| +5% | +$4.09K | ﹤0.01% | 2760 |
|
|
2017
Q3 | $77K | Buy |
565
+43
| +8% | +$5.86K | ﹤0.01% | 2740 |
|
|
2017
Q2 | $101K | Buy |
+522
| New | +$101K | ﹤0.01% | 2721 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$548 | – | 5061 |
|
|
2015
Q2 | $548 | Buy |
+1
| New | +$548 | ﹤0.01% | 5012 |
|